Anelixis Therapeutics

About:

Anelixis Therapeutics is a biotechnology company that facilitates pre-clinical drug development.

Website: http://www.anelixistherapeutics.com

Description:

Anelixis Therapeutics is a clinical stage development company located in Cambridge, Massachusetts with a portfolio focused on immune modulatory drugs for neurodegenerative diseases with a focus on amyotrophic lateral sclerosis (ALS) and Alzheimer's Disease (AD). Anelixis Therapeutics is committed to advancing treatments that will have a meaningful impact on the lives of patients by helping them battle back their disease progression.

Total Funding Amount:

$6.86M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2012-01-01

Founders:

Steve Perrin

Number of Employees:

1-10

Last Funding Date:

2018-04-25

IPO Status:

Private

Industries:

© 2025 bioDAO.ai